Bilateral Thoracoscopic Splanchnotomy for Intractable Upper Abdominal Pain

Chapter 3 Bilateral Thoracoscopic Splanchnotomy for Intractable Upper Abdominal Pain



The videos associated with this chapter are listed in the Video Contents and can be found on the accompanying DVDs and on Expertconsult.com.image


Thoracoscopic splanchnotomy is a minimally invasive procedure that involves the division of the greater and lesser splanchnic sympathetic nerve afferents. The alternative terminology “thoracoscopic splanchnicectomy” that often is applied in the literature is a misnomer because no excision of the splanchnic nerves typically is performed. This procedure has been used to treat chronic severe abdominal pain, mostly from pancreatic disease.


The three splanchnic nerves of the thoracic sympathetic trunk arise from the lower eight ganglia (Figs. 3-1 and 3-2). Branches of the T5-T9 sympathetic ganglia form the greater splanchnic nerve, the T10-T11 ganglia form the lesser splanchnic nerve, and the T12 ganglion forms the least splanchnic nerve. These splanchnic nerves predominantly contain visceral efferent fibers but also carry afferent sympathetic “pain” signals from the upper abdominal viscera, including the pancreas, to the brain. At thoracoscopy, these nerves can be seen running superficial to the intercostal vessels along the vertebral spine (Figs. 3-3 and 3-4), where they can readily be divided.







Operative indications


Chronic pancreatitis represents the most common indication for splanchnotomy. Relief of abdominal pain in patients with chronic pancreatitis poses a challenge to surgeons, gastroenterologists, and pain specialists. As the disease progresses, painful attacks become more frequent with shorter pain-free intervals, culminating in constant and often intractable abdominal pain. The management options include both nonoperative and operative approaches, such as pancreatic enzyme supplementation, nonopioid or opioid analgesia, celiac plexus block with ethanol, thoracoscopic splanchnotomy, decompression of the pancreatic duct, or pancreatic resection. Nonoperative methods may not be effective in achieving pain control in 20% to 50% of patients with chronic pancreatitis; on the other hand, pancreatic surgery carries the potential for long-term morbidity and a small risk for operative mortality. The wide variety of methods available to treat pain associated with chronic pancreatitis reflects the multifactorial nature of this condition, with no single method producing superior results. When selecting these patients for splanchnotomy, it is essential to consider the following:



Exclude alternative causes for pain. Chronic duodenal ulceration is not an uncommon coexisting disorder in chronic pancreatitis patients. It also is essential to exclude pain of drug seekers and those with psychogenic disease.


Reserve splanchnotomy for patients who have visceral rather than somatic pain of chronic pancreatitis. Progression of pancreatitis adds a somatic component to the pain that responds poorly to splanchnotomy. Visceral pain often is described as upper abdominal, whereas back or lower abdominal pain suggests somatic pain. Bradley and colleagues described differential epidural analgesia as a potentially useful method in selecting patients with small duct chronic pancreatitis for thoracoscopic splanchnotomy; patients who responded to sympathetic block were the best candidates for splanchnotomy. Strickland and associates suggested that a favorable response to preoperative paravertebral sympathetic (splanchnic) nerve block with local anesthetic predicted a good response to splanchnotomy.


Exclude disorders that require direct pancreatic surgery. These include pancreatic pseudocyst (internal drainage or distal pancreatectomy might bring symptomatic relief), inflammatory mass in the head of the pancreas (a Beger or Whipple procedure might be necessary), and pancreatic duct dilation with or without stones (which might require a Puestow, Frey, or Beger procedure). Splanchnotomy is reserved for patients with small duct chronic pancreatitis.


Assess severity of the pain. There is no clearly defined threshold for the selection of patients for thoracoscopic splanchnotomy. It is reasonable to reserve this procedure for patients in whom nonoperative measures have been explored and in whom pain severity has required escalating doses of opiates. Thoracoscopic splanchnotomy should not necessarily be the treatment of last resort, however, because its outcome is worst in patients with advanced chronic pancreatitis and previous pancreatic surgery. Although many of these patients may previously have received one or more celiac plexus blocks to relieve the pain with short-lived partial response, failure to achieve any response from such a block might predict poor outcome for thoracoscopic splanchnotomy.


Ensure abstinence from drinking, which is an absolute requirement in patients with alcoholic chronic pancreatitis. Continued alcohol abuse predicts a poor response to thoracoscopic splanchnotomy.


The patient with advanced upper abdominal cancer (e.g., pancreatic, hepatobiliary, or gastric) causing severe abdominal pain may be a candidate for thoracoscopic splanchnotomy. The following points should be considered for this operative indication:


< div class='tao-gold-member'>

Stay updated, free articles. Join our Telegram channel

Jul 20, 2016 | Posted by in GASTOINESTINAL SURGERY | Comments Off on Bilateral Thoracoscopic Splanchnotomy for Intractable Upper Abdominal Pain

Full access? Get Clinical Tree

Get Clinical Tree app for offline access